KOL Lunch on Idiopathic Pulmonary Fibrosis, hosted by Prometic Life Sciences Inc.

The meeting will feature presentations by Key Opinion Leaders (KOLs) Martin Kolb, MD, PhD (McMaster University), and Gerard Criner, MD (Temple University), who will discuss the current treatment landscape, as well as the unmet medical need for treating patients with Idiopathic Pulmonary Fibrosis (IPF).